Showing results (1251-1260 of 1,538) with videos related to

Sort By:
Pageof 154
European Urology Oncology|November 1, 2023
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumKosuke Takemura, Matthew S Ernst, Vishal Navani, et al.
The Journal of Urology|December 27, 2022
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database ConsortiumKosuke Takemura, Vishal Navani, Matthew S Ernst, et al.
JCO Oncology Practice|April 7, 2025
Assessment of Compliance With ASCO Language of Respect Guidelines in Renal Cell Carcinoma AbstractsNazli Dizman, Ruchi Agarwal, Daniela V Castro, et al.
Cancer|January 9, 2019
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancerGuru Sonpavde, Neeraj Agarwal, Gregory Russell Pond, et al.
European Urology|January 27, 2023
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell CarcinomaMatthew S Ernst, Vishal Navani, J Connor Wells, et al.
Clinical Genitourinary Cancer|October 14, 2025
CABOSEQ 3-Comparison of Cabozantinib versus Sunitinib Following First-Line Nivolumab- Ipilimumab for Metastatic Renal Cell Carcinoma: A Target Trial Emulation Using Real-World Data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)Audreylie Lemelin, David Maj, Kosuke Takemura, et al.
JAMA Network Open|June 10, 2022
Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell CarcinomaVishal Navani, Matthew Ernst, J Connor Wells, et al.
Annals of Clinical and Translational Neurology|July 8, 2016
A microRNA-328 binding site in PAX6 is associated with centrotemporal spikes of rolandic epilepsyNaim Panjwani, Michael D Wilson, Laura Addis, et al.
The Oncologist|August 6, 2021
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic DiseaseRisa L Wong, Lorin A Ferris, Olivia A Do, et al.
The Lancet. Oncology|February 16, 2015
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based studyJenny J Ko, Wanling Xie, Nils Kroeger, et al.
Pageof 154